WallStreetZen

NYSE: DHR
Danaher Corp Earnings & Revenue

DHR past earnings growth

How has DHR's earnings growth performed historically?
Company
60.84%
Industry
100.52%
Market
102.72%
DHR's earnings have grown slower (8.42% per year) than the US Diagnostics & Research industry average (24.23%)
Performance
DHR's earnings have grown slower (8.42% per year) than the US market average (27.52%)
Performance
DHR's earnings growth is accelerating - its growth over the last year (60.84%) is above its 5-year compound annual rate (8.42%)
Performance

DHR past revenue growth

How has DHR's revenue growth performed historically?
Company
41.48%
Industry
37.6%
Market
36.32%
DHR's revenue has grown slower (10.8% per year) than the US Diagnostics & Research industry average (17.43%)
Performance
DHR's revenue has grown slower (10.8% per year) than the US market average (17.66%)
Performance
DHR's revenue growth is accelerating - its growth over the last year (41.48%) is above its 5-year compound annual rate (10.8%)
Performance

DHR earnings and revenue history

Current Revenue
$26.7B
Current Earnings
$5.4B
Current Profit Margin
20.4%
DHR's has demonstrated consistent long-term earnings growth over the past 10 years (129.43%)
Performance

DHR Return on equity

Current Company
13.5%
Current Industry
34.1%
Current Market
39.8%
DHR's Return on Equity (13.5%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

DHR Return on assets

Current Company
7.2%
Current Industry
7.7%
Current Market
12.2%
DHR is generating lower Return on Assets (7.2%) than the US Diagnostics & Research industry average (8.12%)
Performance

DHR Return on capital employed

Current Company
9.89%
Current Industry
11.3%
DHR has gotten more efficient at generating Return on Capital (9.89%) compared to 3 years ago (7.6%)
Performance

Danaher Corp Earnings & Revenue FAQ

What were DHR's earnings last quarter?

On Jul 22, 2021, Danaher Corp (NYSE: DHR) reported Q2 2021 earnings per share (EPS) of $2.44, up 92.13% year over year. Total Danaher Corp earnings for the quarter were $1.74 billion. In the same quarter last year, Danaher Corp's earnings per share (EPS) was $1.27.

What was DHR's earnings growth in the past year?

As of Q3 2021, Danaher Corp's earnings has grown 60.84% year over year. This is 39.68 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 100.52%. Danaher Corp's earnings in the past year totalled $5.45 billion.

What was DHR's revenue last quarter?

On Jul 22, 2021, Danaher Corp (NYSE: DHR) reported Q2 2021 revenue of $7.22 billion up 36.27% year over year. In the same quarter last year, Danaher Corp's revenue was $5.30 billion.

What was DHR's revenue growth in the past year?

As of Q3 2021, Danaher Corp's revenue has grown 41.48% year over year. This is 3.88 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 37.6%. Danaher Corp's revenue in the past year totalled $26.72 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.